Loading...

DWTX DOGWOOD THERAPEUTICS INC Earnings Reports 8-K Filing

DGWD

DWTX

DOGWOOD THERAPEUTICS INC

(DWTX)

2023 8-K

Equity Distribution Agreement

Equity Plan Approval

Q3 Earnings Report

Investor Presentation

Licensing Agreement Signed

Financial Results Announced

Compensatory Arrangements o...

Equity Offerings

Financial Statements

Compliance Update

Financial Results

Company Acquisition

Quarterly Results

Nasdaq Compliance

Business Combination

Financial Results Announcement

Annual Meeting Results

Public Offering

Results of Operations

Meeting Approval

Financial Results Announcement

Salary Reduction and Stock ...

Letter to Shareholders

Financial Results Announcement

Regulation FD Disclosure

Termination of Sales Agreement

Financial Results Announcement

FDA Review of Chronic Toxic...

Results of Operations and F...

Annual Meeting Results

Compliance regained with Na...

Earnings Reports

Compliance Extension

Corporate Progress Report

Financial Results Announcement

External Links:

Virios Therapeutics provided a corporate progress report, stating that they had a constructive meeting with the FDA regarding the development of their antiviral therapy for fibromyalgia, and they anticipate results from their Long-COVID trial in June. They also mentioned that they have enough capital to support operations into Q2 2024.

AI Assistant

DOGWOOD THERAPEUTICS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.